UBS Group’s Fennec Pharmaceuticals FENC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$108K Sell
13,024
-13,230
-50% -$110K ﹤0.01% 5914
2025
Q1
$160K Buy
26,254
+10,732
+69% +$65.4K ﹤0.01% 5454
2024
Q4
$98.1K Buy
15,522
+4,299
+38% +$27.2K ﹤0.01% 5674
2024
Q3
$56.1K Buy
11,223
+3,955
+54% +$19.8K ﹤0.01% 5542
2024
Q2
$44.4K Sell
7,268
-22,350
-75% -$137K ﹤0.01% 5634
2024
Q1
$329K Buy
29,618
+9,649
+48% +$107K ﹤0.01% 4380
2023
Q4
$224K Buy
19,969
+9,979
+100% +$112K ﹤0.01% 4542
2023
Q3
$75K Sell
9,990
-542
-5% -$4.07K ﹤0.01% 4909
2023
Q2
$93K Buy
10,532
+9,827
+1,394% +$86.8K ﹤0.01% 5020
2023
Q1
$5.87K Buy
705
+641
+1,002% +$5.33K ﹤0.01% 6881
2022
Q4
$614 Sell
64
-3,035
-98% -$29.1K ﹤0.01% 8919
2022
Q3
$26K Buy
3,099
+3,035
+4,742% +$25.5K ﹤0.01% 5959
2022
Q2
$0 Sell
64
-1,032
-94% ﹤0.01% 9379
2022
Q1
$6K Sell
1,096
-6,681
-86% -$36.6K ﹤0.01% 7907
2021
Q4
$34K Buy
7,777
+7,713
+12,052% +$33.7K ﹤0.01% 6154
2021
Q3
$1K Sell
64
-58,922
-100% -$921K ﹤0.01% 8021
2021
Q2
$430K Buy
58,986
+18,417
+45% +$134K ﹤0.01% 3856
2021
Q1
$252K Buy
40,569
+37,019
+1,043% +$230K ﹤0.01% 4358
2020
Q4
$26K Buy
+3,550
New +$26K ﹤0.01% 5738
2020
Q3
Sell
-6,887
Closed -$58K 7169
2020
Q2
$58K Buy
+6,887
New +$58K ﹤0.01% 4902
2020
Q1
Sell
-983
Closed -$6K 7058
2019
Q4
$6K Sell
983
-1,319
-57% -$8.05K ﹤0.01% 6432
2019
Q3
$11K Buy
2,302
+2,195
+2,051% +$10.5K ﹤0.01% 6131
2019
Q2
$0 Sell
107
-204
-66% ﹤0.01% 7016
2019
Q1
$2K Sell
311
-6,884
-96% -$44.3K ﹤0.01% 6597
2018
Q4
$46K Buy
7,195
+4,396
+157% +$28.1K ﹤0.01% 5260
2018
Q3
$23K Sell
2,799
-1,494
-35% -$12.3K ﹤0.01% 5807
2018
Q2
$45K Buy
+4,293
New +$45K ﹤0.01% 5158
2018
Q1
Sell
-813
Closed -$8K 6936
2017
Q4
$8K Buy
813
+734
+929% +$7.22K ﹤0.01% 6175
2017
Q3
$1K Buy
+79
New +$1K ﹤0.01% 6639